SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-15-004388
Filing Date
2015-09-28
Accepted
2015-09-28 07:02:43
Documents
3
Period of Report
2015-09-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT opxa_8k.htm 8-K 32747
2 CERTIFICATE OF AMENDMENT opxa_ex31.htm EX-3.1 11546
3 PRESS RELEASE opxa_ex991.htm EX-99.1 11178
  Complete submission text file 0001354488-15-004388.txt   57023
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 151126174
SIC: 2834 Pharmaceutical Preparations